Phio Pharmaceuticals Corp. Share Price
PHIOPhio Pharmaceuticals Corp. Stock Performance
Open $1.59 | Prev. Close $1.57 | Circuit Range N/A |
Day Range $1.52 - $1.59 | Year Range $0.96 - $9.79 | Volume 4,112 |
Average Traded $1.55 |
Phio Pharmaceuticals Corp. Share Price Chart
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp., a a clinical stage biotechnology company, engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts.
Phio Pharmaceuticals Corp. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
12-Nov-25 | $1.59 | $1.57 | +0.00% |
12-Nov-25 | $1.59 | $1.57 | -1.88% |
11-Nov-25 | $1.52 | $1.60 | +3.23% |
10-Nov-25 | $1.54 | $1.55 | -0.64% |
07-Nov-25 | $1.54 | $1.56 | +6.48% |
06-Nov-25 | $1.55 | $1.47 | -7.28% |
05-Nov-25 | $1.58 | $1.58 | -2.77% |
FAQs on Phio Pharmaceuticals Corp. Share Price
Can I buy Phio Pharmaceuticals Corp. shares in India?
What is the share price of Phio Pharmaceuticals Corp.?
What is the 5 year returns of Phio Pharmaceuticals Corp.?
What are the high & low stock price of Phio Pharmaceuticals Corp. today?
What is the 52-week high and low of Phio Pharmaceuticals Corp. stock?